HM4: The evolving clinical trial landscape


The European Clinical Trials Regulation (EU CTR) took effect on 31 January 2022. Since then, authorities, sites and sponsors have had to embrace the new Regulation to begin to successfully run clinical trials across the EU. Since 31 January 2023, all clinical trial applications (CTAs) must be submitted through the Clinical Trials Information System (CTIS) and since then, all stakeholders have been dealing with its updates, challenges, revisions and simplifications. In this panel we were fortunate to be able to hear from the different perspectives: EMA, European Commission, industry and consultancy.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.


Not a TOPRA member yet? Join our global community.

Five great reasons to become a TOPRA member:

  1. Great savings on our events and training.
  2. Be part of our dynamic international community.
  3. Contribute to the profession.
  4. Grow your skills and knowledge.
  5. Take your career to the next level.

Have you heard what you’re missing? Listen now to the RegRapPod podcast show, for free!